| 产品描述: | CBP/p300-IN-20 is a potent and selective p300/CBP inhibitor, with a pIC50 of 10.1 for p300. CBP/p300-IN-20 can be used for the research of cancer. |
| 靶点: |
CBP/p300:10.1 (pIC50) |
| 体外研究: |
CBP/p300-IN-20 (compound 28) (0.54 mg/kg; i.v.) exhibits Cmax (210 ng/mL), AUC0→∞ (102 h•ng/mL), CL (95 mL/min/kg), and T1/2 (0.3 h) in rats. |
| 体内研究: |
CBP/p300-IN-20 (compound 28) decreases Myc protein in cell-based cMyc HTRF assay, with a pEC50 of 8.5. CBP/p300-IN-20 (1 μM) shows 97% inhibition for p300 and 80% inhibition for CPB. CBP/p300-IN-20 (0.3-1000 nM; 2 h) decreases H3K18 and H3K27 acetylation without affecting H3K9 acetylation and total H3 in COLO 320HSR cells. |
| 参考文献: |
1. Tian X, et, al. Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening. J Med Chem. 2022 Nov 10;65(21):14391-14408. |
| 保存条件: |
-80°C 6个月;-20°C 1个月 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.093 ml |
10.463 ml |
20.926 ml |
| 5 mM |
0.419 ml |
2.093 ml |
4.185 ml |
| 10 mM |
0.209 ml |
1.046 ml |
2.093 ml |
| 50 mM |
0.042 ml |
0.209 ml |
0.419 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |